4//SEC Filing
Norrett Kevin 4
Accession 0001819690-25-000008
CIK 0001484565other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:49 PM ET
Size
7.7 KB
Accession
0001819690-25-000008
Insider Transaction Report
Form 4
Norrett Kevin
Chief Business Officer
Transactions
- Award
Common Stock
2025-11-17+14,286→ 14,286 total - Exercise/Conversion
Employee stock option (right to buy)
2025-11-17+64,286→ 64,286 totalExercise: $47.25Exp: 2035-11-17→ Common Stock (64,286 underlying)
Footnotes (2)
- [F1]These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. One-half of the RSUs shall vest on November 17, 2026 and one third of the remaining RSUs shall vest each one-year anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
- [F2]One-fourth of the shares subject to the option shall vest on November 17, 2026 and one forty-eighth of the shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
Documents
Issuer
SOLENO THERAPEUTICS INC
CIK 0001484565
Entity typeother
Related Parties
1- filerCIK 0001819690
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 6:49 PM ET
- Size
- 7.7 KB